Company intelligence / Profile preview

Babylon Biosciences

San Francisco, California, United Statesbabylon.bio ↗

Ownership: Private
Employees: ~4
Development stage: Preclinical

Overview

Babylon Biosciences is a San Francisco-based biotech company developing small-molecule therapeutics for diseases of the brain. Their approach focuses on rescuing essential neural functions using a proprietary high-throughput screening platform. The company is in early stages and has not yet reported clinical results or advanced programs to human trials as of early 2025.[1][2][3]

Therapeutic areas: Neurology
Modalities: Small molecules[3]
Industry: Biotech

Partnerships

Mission BioCapital Platinum Program participant—received pre-seed funding and support services from Mission BioCapital and sponsors such as Alloy Therapeutics.[3]

Beyond the preview

Go deeper on Babylon Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Babylon Biosciences.